Ocular symptoms can be the dominant clinical manifestation of rheumatic disease in some cases and knowledge of these relationships can improve the care of both the eye and the joint disease.
Citing recommendations and guidelines from worldwide government agencies and organizations, researchers believe that the consensus supports the safety of vaccinations for patients with rheumatoid arthritis who are undergoing treatment with disease-modifying antirheumatic drugs.
IL-17A inhibitors offer new options in patients with ankylosing spondylitis beyond TNFi agents.
The American Heart Association has updated its scientific statement on blood pressure readings.
Research has shown that Disease Activity Scores are inflated as a result of pain reports that do not reflect actual disease activity in rheumatoid arthritis.
Novel nonsurgical treatments for osteoarthritis are being developed, but the benefits of new treatments must be weighed against their cost and potential risks.
Unexpected findings from the CARES trial have prompted discussion exploring the potential reasons for the observed discrepancy of increased cardiovascular mortality with febuxostat.
This second article devoted to cybersecurity takes a closer look at protecting patients’ privacy.
Curbside consults are commonplace in both hospital and ambulatory settings.
Researchers found that drugs used to treat rheumatoid arthritis have been associated with varicella zoster activation.